|
Volumn 7, Issue 3, 2008, Pages 188-190
|
PPARγ: Ally and Foe in Bone Metabolism
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BORTEZOMIB;
GLITAZONE DERIVATIVE;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;
PIOGLITAZONE;
ROSIGLITAZONE;
ALBERS SCHOENBERG DISEASE;
BONE LESION;
BONE METABOLISM;
BONE REGENERATION;
BONE REMODELING;
CELL DIFFERENTIATION;
CELL LINEAGE;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DRUG MECHANISM;
DRUG TOLERABILITY;
FLUID RETENTION;
FRACTURE;
GENE DELETION;
GLUCOSE METABOLISM;
HUMAN;
LIPID METABOLISM;
MESENCHYMAL STEM CELL;
MULTIPLE MYELOMA;
MULTIPOTENT STEM CELL;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
OSSIFICATION;
OSTEOBLAST;
OSTEOCLAST;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN FUNCTION;
SHORT SURVEY;
SIDE EFFECT;
ANIMALS;
BONE REMODELING;
BONE RESORPTION;
CELL DIFFERENTIATION;
CELL LINEAGE;
HEMATOPOIETIC STEM CELLS;
HUMANS;
MICE;
MICE, KNOCKOUT;
NF-KAPPA B;
OSTEOBLASTS;
OSTEOCLASTS;
OSTEOPETROSIS;
PPAR GAMMA;
PROTO-ONCOGENE PROTEINS C-FOS;
SIGNAL TRANSDUCTION;
THIAZOLIDINEDIONES;
|
EID: 39649112143
PISSN: 15504131
EISSN: None
Source Type: Journal
DOI: 10.1016/j.cmet.2008.02.005 Document Type: Short Survey |
Times cited : (18)
|
References (9)
|